Evidence map›Paper›PMID 27390592›Full record

ArticleJournal of Cancer2016

Overexpression of Transient Receptor Protein Cation Channel Subfamily A Member 1, Confers an Independent Prognostic Indicator in Nasopharyngeal Carcinoma.

You-Ting Wu, Shao-Lun Yen, Chien-Feng Li, Ti-Chun Chan, Tzu-Ju Chen, Sung-Wei Lee, Hong-Lin He, I-Wei Chang, Chung-Hsi Hsing, Yow-Ling Shiue

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Role of TRP Channels in Cancer-Induced Bone Pain.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. A novel strategy for treating cancer: understanding the role of CaExploration of targeted anti-tumor therapy · 2021
    Review
  8. Distribution and Assembly of TRP Ion Channels.Advances in experimental medicine and biology · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

You-Ting Wu1. Departments of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan;; 2. Department of Pathology, Chang Gung Memorial Hospital, Chia-Yi, Taiwan;
Shao-Lun Yen1. Departments of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan;
Chien-Feng Li3. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan;; 4. National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan;; 5. Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan;; 6. Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;
Ti-Chun Chan3. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan;
Tzu-Ju Chen3. Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan;
Sung-Wei Lee7. Department of Radiation Oncology, Chi-Mei Medical Center, Liouying, Tainan, Taiwan;
Hong-Lin He8. Department of Pathology, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan;; 9. Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan;
I-Wei Chang8. Department of Pathology, E-DA Hospital, I-Shou University, Kaohsiung, Taiwan;
Chung-Hsi Hsing10. Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan;
Yow-Ling Shiue9. Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan;; 11. Department of Biological Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan;; 12. Doctoral degree program in Marine Biotechnology, National Sun Yat-sen University, Kaohsiung, Taiwan.
Chi Mei Medical Center · TWKaohsiung Chang Gung Memorial Hospital · TWNational Sun Yat-sen University · TWChang Gung University · TWI-Shou University · TWSouthern Taiwan University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDetection of oncogenes provides chances to understand tumor development and progression. Transient receptor protein cation channel subfamily A, member 1 (TRPA1) transcript was significantly upregulated in nasopharyngeal carcinoma (NPC) with a stepwise upregulation from low- to high-stage NPCs from a preliminary data analysis in the Gene Expression Omnibus database. The TRPA1 gene is a member of the TRP channel family, encoding integral membrane proteins that functions as cation channels. Loss of calcium homeostasis takes place in cancer cells.

methodsImmunostaining of TRPA1 was analyzed on 124 biopsies from NPC patients retrospectively. The H-score method was used to evaluate the immunoexpression of TRPA1. The correlations between H-score of TRPA1 protein level and clinicopathological factors, as well as the significances of TRPA1 protein level for disease-specific, distal-metastasis-free and local recurrence-free survivals were assessed.

resultsThese patients were characterized to be no initial metastasis and medicated with the traditional procedure. The TRPA1 score was found to be associated with clinicopathological parameters and patient survivals. Along with the guideline of 7(th) edition of the American Joint Committee on Cancer, we found that TRPA1 upregulation (50%) was associated with advanced primary tumor (P = 0.009) and overall clinical stage (P = 0.019). In univariate log-rank testing, primary tumor, nodal status, stage and TRPA1 protein level significantly contributed to worse disease-specific survival, distal metastasis-free survival and local recurrence-free survival. In multivariate analysis, high TRPA1 protein level and tumor stage emerged as independent prognostic indicators for inferior disease-specific survival (P = 0.014; P = 0.003), distal metastasis-free survival (P = 0.004; P = 0.034) and recurrence-free survival (P = 0.017; P = 0.015).

conclusionsThe upregulation of TRPA1 protein level is frequently correlated to unfavorable prognosticators and gives rise to cancer progression in NPC patients.

Indexed as

nasopharyngeal carcinomaprognosis.TRPA1

Identifiers

PMID27390592
PMCPMC4934025
OpenAlexW2439842035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.